Efficacy of Biofeedback-Assisted Pelvic Muscle Floor Training and Electrical Stimulation on Women With Stress Urinary Incontinence
1 other identifier
interventional
128
1 country
1
Brief Summary
The pathophysiological mechanism of stress urinary incontinence divides stress urinary incontinence into urethral hypermobility and intrinsic sphincter deficiency. Pelvic floor muscle exercise as first line therapy has been found to be extremely helpful in patients with mild to moderate forms of incontinence. Biofeedback uses an instrument to record the biological signals ( electrical activity) during a voluntary pelvic floor muscle contraction and present this information back to the woman in auditory or visual form. Electrical stimulation can aid in detecting pelvic floor muscles, and also promote the contraction of the pelvic floor muscles and strengthen the muscles. This study assumes that urinary incontinence women with different pathophysiological classifications receiving a pelvic floor muscle training with surface electromyographic biofeedback and electrical stimulation show differences in the strength of pelvic muscle and degree of symptoms improvement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2022
CompletedFirst Posted
Study publicly available on registry
March 9, 2022
CompletedStudy Start
First participant enrolled
September 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedMarch 22, 2023
March 1, 2023
1.3 years
February 28, 2022
March 20, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
King's Health Questionnaire (KHQ)
KHQ has 3 parts consisting of 21 items. Part 1 contains general health perception and incontinence impact (one item each). Part 2 contains role limitations, physical limitations, social limitations (two items each), personal relationships, emotions (three items each) and sleep/energy (two items), severity measures (four items).Part 3 is considered as a single item and contains ten responses in relation to frequency, nocturia, urgency,urge, stress, intercourse incontinence, nocturnal enuresis,infections, pain, and difficulty in voiding. The 4 subscales scored between 1 (best) and 4 (worst) in part 1 and 2. The Symptom Severity scale is scored from 0 (best) to 3 (worst) in part 3 .
Time Frame: through study completion, an average of 8 weeks
A five-item Self-Assessment of Treatment (SAT)
to assess improvement and satisfaction with treatment, consists of 1 item. The scale scored between 1 (worst) and 5 (best ) .
Time Frame: through study completion, an average of 8 weeks.
Sandvik urinary incontinence severity test
The Sandvik test was developed by Sandvik et al to be used as a simple way to calculate severity of urinary incontinence in women. Answer the two questions below and your result will be displayed (Severity Index Score).
Time Frame: through study completion, an average of 8 weeks
Symptom Indexes for Stress Incontinence
assigning a grade based on a clinical history of incontinence: grade 1-only on Severe coughing, sneezing, lifting heavy objects, lifting heavy objects, jumping; grade 2-on walking or running; grade 3-on walking, doing housework (eg washing dishes, sweeping the floor), changing posture (eg from standing to squatting or sitting...);grade 4-on Resting state, such as turning over in bed
Time Frame: through study completion, an average of 8 weeks
Secondary Outcomes (3)
Introital and transvaginal ultrasound in the assessment of urogenital and pelvic floor dysfunction
Time Frame: through study completion, an average of 8 weeks
one-hour pad test
Time Frame: through study completion, an average of 8 weeks
change of electromyographic activity
Time Frame: through study completion, an average of 8 weeks
Study Arms (4)
urethral hypermobility-surface electromyographic biofeedback only
ACTIVE COMPARATORParticipant will be doing surface electromyographic biofeedback assisted pelvic floor muscle training for 2 months
urethral hypermobility-surface electromyographic biofeedback and electrical stimulation
EXPERIMENTALParticipant will be doing surface electromyographic biofeedback and electrical stimulation assisted pelvic floor muscle training for 2 months
intrinsic sphincter deficiency-surface electromyographic biofeedback only
ACTIVE COMPARATORParticipant will be doing surface electromyographic biofeedback assisted pelvic floor muscle training for 2 months
intrinsic sphincter deficiency-surface electromyographic biofeedback and electrical stimulation
EXPERIMENTALParticipant will be doing surface electromyographic biofeedback and electrical stimulation assisted pelvic floor muscle training for 2 months
Interventions
participants will be doing surface electromyographic biofeedback assisted pelvic floor muscle training for 2 months
participants will be doing surface electromyographic biofeedback and electrical stimulation assisted pelvic floor muscle training for 2 months
Eligibility Criteria
You may qualify if:
- overactivity bladder for more than 3 months
- more then 20 year old,less then 85 year old and acceptable to receive vaginal examination
- need to match schedule with the investigator's clinic for 45 times,followed by individual therapy, each takes about 30 to 60 minutes, a total of 8 weeks of pelvic floor muscle exercises
You may not qualify if:
- Suffering from systemic neuromuscular diseases, such as stroke, spinal cord injury, peripheral neuropathy, etc.
- Kidney disease
- Liver disease
- Patients with cardiac rhythm devices.
- Insufficient cognitive function, unable to cooperate with pelvic floor muscle exercises.
- Women during pregnancy.
- Maternity within six weeks after delivery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Far Eastern Memorial Hospital
New Taipei City, 220, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 28, 2022
First Posted
March 9, 2022
Study Start
September 16, 2022
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
March 22, 2023
Record last verified: 2023-03